Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Mateos

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Leukemia|February 16, 2012
Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patientsB Paiva, N-C Gutiérrez, X Chen, et al.
Leukemia|November 13, 2014
Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potentialT Paíno, B Paiva, J M Sayagués, et al.
Leukemia|February 18, 2017
Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myelomaJ Martinez-Lopez, B Sanchez-Vega, S Barrio, et al.
The Journal of Molecular Diagnostics : JMD|November 19, 2016
A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple MyelomaCristina Jiménez, María Jara-Acevedo, Luis A Corchete, et al.
Hemasphere|February 20, 2026
A critical analysis of the IMWG multiple myeloma complete response criterion in the era of mass spectrometryNoemí Puig, Cristina Agulló, Bruno Paiva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcomeM Constans, A Sureda, M J Terol, et al.
Hemasphere|December 12, 2024
High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experienceVeronica González-Calle, Paula Rodriguez-Otero, Maria J Calasanz, et al.
Leukemia|January 22, 2011
Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myelomaB Paiva, M Pérez-Andrés, M-B Vídriales, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2005
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapseA Sureda, M Constans, A Iriondo, et al.
Leukemia|November 21, 2008
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disordersA Dispenzieri, R Kyle, G Merlini, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Leukemia|February 16, 2012
Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patientsB Paiva, N-C Gutiérrez, X Chen, et al.
Leukemia|November 13, 2014
Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potentialT Paíno, B Paiva, J M Sayagués, et al.
Leukemia|February 18, 2017
Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myelomaJ Martinez-Lopez, B Sanchez-Vega, S Barrio, et al.
The Journal of Molecular Diagnostics : JMD|November 19, 2016
A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple MyelomaCristina Jiménez, María Jara-Acevedo, Luis A Corchete, et al.
Hemasphere|February 20, 2026
A critical analysis of the IMWG multiple myeloma complete response criterion in the era of mass spectrometryNoemí Puig, Cristina Agulló, Bruno Paiva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcomeM Constans, A Sureda, M J Terol, et al.
Hemasphere|December 12, 2024
High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experienceVeronica González-Calle, Paula Rodriguez-Otero, Maria J Calasanz, et al.
Leukemia|January 22, 2011
Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myelomaB Paiva, M Pérez-Andrés, M-B Vídriales, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2005
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapseA Sureda, M Constans, A Iriondo, et al.
Leukemia|November 21, 2008
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disordersA Dispenzieri, R Kyle, G Merlini, et al.
Pageof 18